- Home
- AKAN vs PTIX Comparison
AKAN vs PTIX Comparison
Compare AKAN & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKAN
- PTIX
- Stock Information
- Founded
- AKAN 2021
- PTIX 1994
- Country
- AKAN United Kingdom
- PTIX United States
- Employees
- AKAN N/A
- PTIX N/A
- Industry
- AKAN Medicinal Chemicals and Botanical Products
- PTIX Biotechnology: Pharmaceutical Preparations
- Sector
- AKAN Health Care
- PTIX Health Care
- Exchange
- AKAN Nasdaq
- PTIX Nasdaq
- Market Cap
- AKAN 1.7M
- PTIX 2.0M
- IPO Year
- AKAN 2022
- PTIX 2016
- Fundamental
- Price
- AKAN $1.15
- PTIX $0.22
- Analyst Decision
- AKAN
- PTIX
- Analyst Count
- AKAN 0
- PTIX 0
- Target Price
- AKAN N/A
- PTIX N/A
- AVG Volume (30 Days)
- AKAN 33.7K
- PTIX 10.5M
- Earning Date
- AKAN 05-09-2025
- PTIX 05-14-2025
- Dividend Yield
- AKAN N/A
- PTIX N/A
- EPS Growth
- AKAN N/A
- PTIX N/A
- EPS
- AKAN N/A
- PTIX N/A
- Revenue
- AKAN $2,508,317.00
- PTIX N/A
- Revenue This Year
- AKAN N/A
- PTIX N/A
- Revenue Next Year
- AKAN N/A
- PTIX N/A
- P/E Ratio
- AKAN N/A
- PTIX N/A
- Revenue Growth
- AKAN N/A
- PTIX N/A
- 52 Week Low
- AKAN $0.93
- PTIX $0.18
- 52 Week High
- AKAN $47.52
- PTIX $1.87
- Technical
- Relative Strength Index (RSI)
- AKAN 39.12
- PTIX 42.85
- Support Level
- AKAN $1.08
- PTIX $0.21
- Resistance Level
- AKAN $1.24
- PTIX $0.25
- Average True Range (ATR)
- AKAN 0.10
- PTIX 0.03
- MACD
- AKAN 0.01
- PTIX -0.01
- Stochastic Oscillator
- AKAN 70.97
- PTIX 9.82
About AKAN Akanda Corp.
Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The Company has three reportable segments: Cultivation, Distribution, and Corporate. Cultivating activities comprise the cultivation segment made up of the medical cannabis cultivation operations at RPK/Holigen in Portugal, and medical cannabis cultivation activities. Distributing activities relate to the distribution of medical cannabis by Canmart Ltd in the United Kingdom. Corporate activities entail head office costs and other general corporate expenses related to the administration of the broader group.
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.